论文部分内容阅读
目的:分析肾脏疾病患者应用生化免疫检查的临床有效性。方法:选取2014年9月至2015年9月该院收治的肾脏疾病患者80例,随机分成对照组与观察组,各40例,对照组根据免疫学进行检查,而观察组患者则是根据免疫学与生化学检进行检查,分析两组肾脏疾病患者的临床诊断效果。结果:观察组临床治疗准确率为97.5%,明显优于对照组的(82.5%,P<0.05);观察组的β2微球蛋白、肌酐与尿素等检测水平比对照组低,而24 h尿蛋白量比对照组高(P<0.05)。结论:临床生化检查和免疫检查技术联合应用,可以提高肾脏疾病临床检查有效性,给肾脏疾病的临床治疗提供关键依据,具有临床应用的价值。
Objective: To analyze the clinical efficacy of biochemical immunoassay in patients with kidney disease. Methods: Eighty patients with renal diseases admitted from September 2014 to September 2015 in our hospital were randomly divided into control group and observation group, 40 cases in each group. The control group was examined according to immunology, while the observation group was based on immunization Learning and biochemical examination for examination, analysis of two groups of patients with renal disease clinical diagnosis. Results: The accuracy rate of clinical observation in the observation group was 97.5%, which was significantly better than that in the control group (82.5%, P <0.05). The detection level of β2 microglobulin, creatinine and urea in the observation group was lower than that in the control group, The protein level was higher in the control group (P <0.05). Conclusion: The combination of clinical biochemical tests and immunological tests can improve the effectiveness of clinical examination of renal diseases and provide the key basis for the clinical treatment of renal diseases, which has the value of clinical application.